Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-47831

Single-particle
3.1 Å
EMD-47831
3D View Gallery
Deposition: 11/11/2024
Map released: 05/03/2025
Last modified: 26/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47831
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9eah summary report (pdf.gz) Map and 9eah FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of nanobody AT209 in complex with the olmesartan-bound angiotensin II type I receptor (AT1R)

EMD-47831

Single-particle
3.1 Å
EMD-47831
3D View Gallery
Deposition: 11/11/2024
Map released: 05/03/2025
Last modified: 26/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, synthetic construct
Sample: nanobody AT209 in complex with the olmesartan-bound angiotensin II type I receptor (AT1R)
Fitted models: 9eah

Deposition Authors: Skiba MA , Kruse AC
Epitope-directed selection of GPCR nanobody ligands with evolvable function.
Skiba MA , Canavan C , Nemeth GR, Liu J, Kanso A , Kruse AC
(2025) PNAS , 122 , e2423931122 - e2423931122
PUBMED: 40067891
DOI: doi:10.1073/pnas.2423931122
ISSN: 1091-6490
ASTM: PNASA6